CDSA 2.0™ w/o Parasitology (Comprehensive Digestive Stool Analysis 2.0)

CDSA 2.0™ without Parasitology Stool Analysis Offers Insight into Common Gastrointestinal Conditions

Proceed to Clinical Overview

The Comprehensive Digestive Stool Analysis 2.0™ without Parasitology (CDSA 2.0) offers unique insight into overall gastrointestinal health by assessing a combination of novel stool biomarkers

This stool analysis evaluates:

  • Digestion/Absorption Markers
  • Immunology (Inflammation) Markers

    • Pancreatic Elastase 1 (PE1), a biomarker of exocrine pancreatic function Immunology (Inflammation) Markers
    • Calprotectin, an FDA-cleared biomarker that effectively differentiates between Irritable Bowel Syndrome (IBS) and Inflammatory Bowel Disease (IBD)

  • Gut Metabolic Markers
  • Gut Microbiology Markers

This diagnostic stool analysis provides immediate, actionable clinical information for the estimated 50% of patients seen by primary care practitioners who have gastrointestinal complaints. For greater insight into the clinical utility of the CDSA 2.0™ without Parasitology, please read the Clinical Overview.

CDSA 2.0 Stool Analysis without parasitology offers Insight into Common Gastrointestinal Conditions

Evidence suggests that both local and systemic health issues may begin as imbalances in gastrointestinal function. Some of the consequences of imbalanced gastrointestinal health are:

  • Maldigestion
  • Malabsorption
  • Irritable Bowel Syndrome (IBS)
  • Altered GI immune function
  • Bacterial/fungal overgrowth
  • Chronic dysbiosis

For an even deeper look into gut health, we also offer CDSA 2.0™ which includes Parasitology.



Clinical Overview

What is the Comprehensive Digestive Stool Analysis 2.0™ without parasitology?

The Comprehensive Digestive Stool Analysis 2.0™ without parasitology provides unique insight into overall and gastrointestinal health by assessing a combination of novel stool biomarkers. The CDSA 2.0 without parasitology provides an informative and flexible screening of gastrointestinal function providing information on:

  • Digestion/Absorption:
    • Pancreatic Elastase 1
    • Putrefactive Short–Chain Fatty Acids
    • Additional biomarkers available
      • Chymotrypsin
      • Fecal Fats
  • Inflammation/Immunology:
    • Eosinophil Protein X (EPX)
    • Calprotectin
  • Gut Metabolic Markers
    • Beneficial Short–Chain Fatty Acids (SCFA) with n–Butyrate
    • pH
    • Beta–Glucuronidase
    • Secondary Bile Acids
      • Lithocholic acid (LCA)
      • Deoxycholic acid (DCA)
      • LCA/DCA Ratio
  • Gut Microbiology Markers
    • Beneficial Bacteria
    • Additional Bacteria
    • Mycology

When should the CDSA 2.0 without parasitology be considered?

CDSA2.0 without parasitology can reveal important clinical information about many common symptoms such as gas, bloating, abdominal pain, diarrhea, and constipation. This stool analysis also provides assessment for a differential diagnosis between inflammatory bowel disease and irritable bowel syndrome, plus a reliable assessment of exocrine pancreatic function.

What advantage does the CDSA 2.0 without parasitology offer compared to other diagnostics?

Traditional GI testing has required advanced imaging and inconvenient testing procedures that can be costly. The CDSA 2.0 without parasitology stool analysis offers a user-friendly way to provide clinicians with valuable insight into GI imbalances.

What can clinicians and patients expect from CDSA 2.0 without parasitology offer compared to other diagnostics ?

Evidence suggests that both local and systemic health issues may begin as imbalances in Gastrointestinal function. The CDSA 2.0 without parasitology stool test provides immediate, actionable clinical information for patients presenting with GI complaints. It aids clinicians in the identification of root cause(s) of digestive discomfort and supports identification of targeted treatments.

Test Type: Stool Analysis

Analyte List
Anti-Microbial Sensitivities: (Prescriptive and natural agents tested on an individual basis)
Bacteriology Culture - Beneficial Bacteria (Bifidobacterium, E.Coli, Lactobacillus)
Bacteriology Culture - Imbalanced and dysbiotic flora
Beneficial SCFA
Beta-Glucuronidase
Calprotectin
Campylobacter Specific Antigen (EIA)
Eosinophil Protein X (EPX)
Mycology (yeast culture)
Pancreatic Elastase 1
Putrefactive SCFAs
Secondary Bile Acids (Lithocholic acid (LCA), Deoxycholic acid (DCA) and ratio)
Shiga-like Toxin E coli (EIA)
n-Butyrate %
pH
Specimen Requirements
1 Cary Blair - 1 Formalin; 40ml stool in white-top cup.